SciELO - Scientific Electronic Library Online

 
vol.82 número3  suppl.Vacinação contra Haemophilus influenzae tipo b: proteção a longo prazo índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Jornal de Pediatria

versão impressa ISSN 0021-7557versão On-line ISSN 1678-4782

Resumo

SILVA, Luiz Jacintho da  e  RICHTMANN, Rosana. Vaccines under development: group B streptococcus, herpes-zoster, HIV, malaria and dengue. J. Pediatr. (Rio J.) [online]. 2006, vol.82, n.3, suppl., pp.s115-s124. ISSN 0021-7557.  http://dx.doi.org/10.1590/S0021-75572006000400014.

OBJECTIVES: To review the current state of development of streptococcus B, herpes-zoster, HIV, malaria and dengue vaccines. These vaccines were selected both because of imminent commercial release and because of specific problems with their development. SOURCES OF DATA: A review of the literature was performed by means of a MEDLINE search, on the period 1996 to 2006, for the epidemiology and immunology of these diseases, analyzing both the greatest obstacles to creating a vaccine and the current state of research, with emphasis on studies in the most advanced stages. SUMMARY OF THE FINDINGS: Each of the five diseases chosen presents specific problems for vaccine development. Nevertheless, in the majority of cases these have been or are in sight of being resolved, allowing for the prediction that a safe and effective vaccine - or vaccines - will be available in the near future. CONCLUSIONS: Despite the problems faced in developing these vaccines, advances in molecular biology and immunology have made it possible to overcome most obstacles, opening up the prospects for new vaccines.

Palavras-chave : Streptococcus B; herpes-zoster; malaria; dengue; AIDS; HIV; vaccine.

        · resumo em Português     · texto em Português | Inglês     · Português ( pdf epdf ) | Inglês ( pdf epdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons